在二次心血管预防中采用多药药剂策略
Alan De la Rosa1, Kedzie Arrington2, Rohan Desai3
1Division of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
多种药丸策略改善了药物守和心血管健康. 长期研究证实了其在预防主要心血管不良事件 (MACE) 中的非劣势性,特别是在多样化的人群中.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 该多药药策略旨在改善心血管疾病管理的药物坚持.
- 之前的试验表明,多药药有效降低血压和胆固醇.
- 对主要不良心血管事件 (MACE) 的长期临床影响仍然不确定.
研究的目的:
- 评估多药药策略对MACE结果的长期临床影响.
- 评估多药在二次心血管预防中的有效性和安全性.
- 检查多药在多样化和服务不足的人群中的有效性.
主要方法:
- 分析最近的临床试验与长期随访数据.
- 包括专注于少数群体和社会经济地位较低的个人研究.
- 与标准医疗治疗相比,多药药策略的结果的比较.
主要成果:
- 最近的长期试验表明,多药剂策略对二次MACE预防的非劣势性.
- 与标准护理相比,没有观察到副作用率的显著差异.
- 多药丸策略已被证明是有效的改善药物遵守,特别是在服务不足的人群.
- 多种药丸的策略超过了标准的医疗治疗对MACE结果的二次预防.
结论:
- 多药丸策略是一种安全有效的选择,用于MACE的二次预防.
- 它在药物坚持方面提供了显著的好处,特别是在脆弱的患者群体中.
- 多种药丸策略代表了超越标准医疗治疗以减少心血管风险的进步.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Preventive Healthcare Services
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
